A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy

Table 1 Inclusion criteria

1 Diagnosed with TAO
2 CAS ≥3/7
3 Contrast-enhanced orbital MRI showed increased signal intensity of extraocular muscles
4 Received 4.5 g intravenous methylprednisolone therapy

Patients should have met either criteria 2 or 3, together with criteria 1 and 4 to be included in the study. TAO thyroid-associated ophthalmopathy, CAS clinical activity score, MRI magnetic resonance imaging

ISSN: 1472-6823